CARDINAL HEALTH’S LEADERSHIP IN DEVELOPING THE CIRCULAR HEALTHCARE ECONOMY IN AUSTRALIAN MEDICAL DEVICES
With
Neroli Manning,
Managing Director
Cardinal Health – Australia & New Zealand
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | May 2026
Neroli Manning is the Managing Director for Cardinal Health Australia & New Zealand (ANZ). With over 30 years of experience in the healthcare industry, Neroli is a transformative leader known for her people-first, customer-centric leadership style.
Her career spans Australia, New Zealand, and the Asia Pacific region, where she has held senior management roles in the medical device, capital equipment, and radiopharmaceutical sectors with global leaders like CR Bard, Medtronic, Philips, Abbott, and Sirtex.
Neroli’s leadership is defined by her ability to drive change, foster collaboration, and build high-performing teams. Additionally, having held a variety of senior commercial functional positions, she is able to leverage her deep experience and cross-functional insights to align teams, streamline operations, and deliver strategic outcomes. She is also passionate about mentoring emerging leaders and shaping the future of healthcare through inclusive, values-driven leadership.
As a founder of her own healthcare consulting firm, Neroli demonstrated entrepreneurial leadership, guiding global medical device companies through complex market challenges. Her legacy includes cultivating cultures of accountability, innovation, and continuous learning.
Beyond leading Cardinal Health’s operations in ANZ, Neroli also contributes to the broader industry as a company director and member of the Industry Policy Committee for the Medical Technology Association of Australia (MTAA).
Neroli has a Master’s of Business (Marketing) degree from the University of Technology, Sydney. In her spare time, she enjoys spending time with friends and family, exercising, working on her farm, travelling and playing golf.
Source: Supplied
-
New bar for cosmetic plastic surgeon accreditation
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
-
Closing the diagnostic gap in ovarian cancer detection
After 15 years in academia, Associate Professor Michelle Hill founded ProSeek bio to address one of the most urgent challenges in women’s health: closing the diagnostic gap in ovarian cancer.
For too long, women suspected of ovarian cancer have faced an impossible choice — undergo invasive surgery for diagnosis, only for up to 80% of those procedures to reveal no cancer, or delay intervention and risk diagnosis at a later stage when treatment options are fewer and survival outcomes are significantly worse.
-
Allied Health Leader shares career insights
Mirella Vagnarelli is a distinguished healthcare leader with proven expertise across South Australia and the United Kingdom, where she has successfully led large, multidisciplinary teams. Holding a Master of Business Administration (Health) from Flinders University, she earned Fellowship status with the Australasian College of Health Service Management in 2022. In 2023, Mirella was honoured as a scholarship recipient for the prestigious ‘Women in Leadership’ Program at the Monash Centre for Health Research and Implementation.
